Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer-Reference-Cited by-同舟云学术

Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer

Published:2022-03 Issue: Volume:165 Page:115-123
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Wu Junqi,Hou Likun,E Haoran,Zhao Yue,Yu Xin,Xu Long,Ning Ye,Deng Jiajun,Sun Ke,Zhang Jie,Wu Chunyan,Zhu Yuming,Zhao Deping,She Yunlang,Su Chunxia,Chen Chang

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference43 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA A Cancer J Clin,2021

2. The International Association for the Study of Lung Cancer Lung Cancer Staging Project;Asamura;Journal of Thoracic Oncology,2015

3. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer;Martin;J Clin Oncol.,2002

4. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol.,2008

5. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer;Brahmer;N Engl J Med.,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A2ST-GCM: An adaptive spatio-temporal aware graph convolutional model for predicting pathological complete response in neoadjuvant therapy;Biomedical Signal Processing and Control;2025-01

2. Tertiary Lymphoid Structure in Tumor Microenvironment and Immunotherapy of Lung Cancer;Archivos de Bronconeumología;2024-07

3. Efficacy and safety of different cycles of neoadjuvant immunotherapy in resectable non-small cell lung cancer: A systematic review and meta-analysis;Heliyon;2024-06

4. Efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer: a real-world, multicenter, retrospective study;Translational Lung Cancer Research;2024-04

5. Perioperative Immunotherapy for Node-Negative Non-Small Cell Lung Cancer—Current Evidence and Future Directions;The Annals of Thoracic Surgery;2024-04